MEI Pharma Inc (MEIP)
3.06
-0.04
(-1.29%)
USD |
NASDAQ |
Apr 26, 16:00
3.06
0.00 (0.00%)
After-Hours: 19:44
MEI Pharma Cash from Financing (TTM): -11.66M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.66M |
September 30, 2023 | 0.00 |
June 30, 2023 | -0.04M |
March 31, 2023 | -0.02M |
December 31, 2022 | 0.34M |
September 30, 2022 | 49.20M |
June 30, 2022 | 49.05M |
March 31, 2022 | 49.10M |
December 31, 2021 | 48.86M |
September 30, 2021 | 0.014M |
June 30, 2021 | 3.468M |
March 31, 2021 | 24.23M |
December 31, 2020 | 24.10M |
September 30, 2020 | 72.53M |
June 30, 2020 | 74.78M |
March 31, 2020 | 54.22M |
December 31, 2019 | 54.48M |
September 30, 2019 | 6.054M |
June 30, 2019 | 1.386M |
March 31, 2019 | 71.14M |
December 31, 2018 | 70.88M |
September 30, 2018 | 71.03M |
June 30, 2018 | 70.21M |
March 31, 2018 | 0.189M |
December 31, 2017 | 0.189M |
Date | Value |
---|---|
September 30, 2017 | 0.02M |
June 30, 2017 | 4.212M |
March 31, 2017 | 4.212M |
December 31, 2016 | 4.212M |
September 30, 2016 | 4.212M |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | 39.45M |
March 31, 2013 | 30.06M |
December 31, 2012 | 30.11M |
September 30, 2012 | 6.753M |
June 30, 2012 | 9.425M |
March 31, 2012 | 5.282M |
December 31, 2011 | 6.013M |
September 30, 2011 | 4.048M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-11.66M
Minimum
Dec 2023
74.78M
Maximum
Jun 2020
26.32M
Average
24.10M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Merck & Co Inc | -4.81B |
United Therapeutics Corp | -11.90M |
Macrogenics Inc | 150.36M |
Voyager Therapeutics Inc | 33.64M |
Moderna Inc | -1.377B |